Your browser doesn't support javascript.
loading
Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial.
Yassi, Nawaf; Zhao, Henry; Churilov, Leonid; Campbell, Bruce C V; Wu, Teddy; Ma, Henry; Cheung, Andrew; Kleinig, Timothy; Brown, Helen; Choi, Philip; Jeng, Jiann-Shing; Ranta, Annemarei; Wang, Hao-Kuang; Cloud, Geoffrey C; Grimley, Rohan; Shah, Darshan; Spratt, Neil; Cho, Der-Yang; Mahawish, Karim; Sanders, Lauren; Worthington, John; Clissold, Ben; Meretoja, Atte; Yogendrakumar, Vignan; Ton, Mai Duy; Dang, Duc Phuc; Phuong, Nguyen Thai My; Nguyen, Huy-Thang; Hsu, Chung Y; Sharma, Gagan; Mitchell, Peter J; Yan, Bernard; Parsons, Mark W; Levi, Christopher; Donnan, Geoffrey A; Davis, Stephen M.
Afiliação
  • Yassi N; Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia nawaf.yassi@unimelb.edu.au.
  • Zhao H; Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Churilov L; Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.
  • Campbell BCV; Ambulance Victoria, Melbourne, Victoria, Australia.
  • Wu T; Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.
  • Ma H; Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.
  • Cheung A; Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.
  • Kleinig T; Stroke Division, The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
  • Brown H; Department of Neurology, Christchurch Hospital, Christchurch, New Zealand.
  • Choi P; Department of Neurology, Monash Medical Centre, Monash University, Clayton, Victoria, Australia.
  • Jeng JS; Department of Interventional Neuroradiology, Liverpool Hospital, Liverpool, New South Wales, Australia.
  • Ranta A; Department of Neurology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Wang HK; Department of Neurology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
  • Cloud GC; Department of Neurology, Box Hill Hospital, Eastern Health, Box Hill, Victoria, Australia.
  • Grimley R; Stroke Centre and Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
  • Shah D; Department of Medicine, Dunedin School of Medicine, University of Otago, Wellington, New Zealand.
  • Spratt N; Department of Neurosurgery, E-Da Hospital, Yanchao, Kaohsiung, Taiwan.
  • Cho DY; Department of Neurology, Alfred Hospital, Melbourne, Victoria, Australia.
  • Mahawish K; Department of Clinical Neuroscience, Monash University Central Clinical School, Melbourne, Victoria, Australia.
  • Sanders L; Department of Medicine, Sunshine Coast University Hospital, Nambour, Queensland, Australia.
  • Worthington J; Department of Neurology, Gold Coast University Hospital, Southport, Queensland, Australia.
  • Clissold B; Department of Neurology, John Hunter Hospital, The University of Newcastle, Newcastle, New South Wales, Australia.
  • Meretoja A; Department of Neurosurgery, China Medical University Hospital, Taichung, Taiwan.
  • Yogendrakumar V; Department of Internal Medicine, Palmerston North Hospital, Palmerston North, New Zealand.
  • Ton MD; Department of Neurology, St Vincent's Hospital, Fitzroy, Victoria, Australia.
  • Dang DP; Department of Neurology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
  • Phuong NTM; Department of Neurology, Geelong Hospital, Geelong, Victoria, Australia.
  • Nguyen HT; Department of Neurology, Helsinki University Hospital, Helsinki, Finland.
  • Hsu CY; Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.
  • Sharma G; Stroke Center, Bach Mai Hospital, Hanoi, Viet Nam.
  • Mitchell PJ; Stroke Department, 103 Military Hospital, Hanoi, Hanoi, Viet Nam.
  • Yan B; Department of Neurology, Nguyen Tri Phuong Hospital, Ho Chi Minh City, Viet Nam.
  • Parsons MW; Department of Cerebrovascular Disease, 115 Hospital, Ho Chi Minh City, Viet Nam.
  • Levi C; Department of Neurology, China Medical University, Taichung, Taiwan.
  • Donnan GA; Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.
  • Davis SM; Department of Radiology, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia.
Stroke Vasc Neurol ; 7(2): 158-165, 2022 04.
Article em En | MEDLINE | ID: mdl-34848566
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Tranexâmico / Hemorragia Cerebral Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Tranexâmico / Hemorragia Cerebral Idioma: En Ano de publicação: 2022 Tipo de documento: Article